Edgewise Therapeutics Inc. has granted a new non-executive employee a stock option to purchase 26,250 shares of the company's common stock at an exercise price of $26.04 per share, matching the closing price on the grant date. Under the terms, 25% of the shares will vest on the employee's one-year anniversary, with the remaining shares vesting monthly over the following three years, contingent on continued employment. This grant was made under Edgewise's 2024 Inducement Equity Incentive Plan.